Earnest, Jami
Supernus Pharmaceuticals (United States)
2 papers on CoChat
Most cited papers
- Verified
Viloxazine extended-release capsules as an emerging treatment for attention-deficit/hyperactivity disorder in children and adolescents
Maletic, V., Mattingly, G. W., & Earnest, J. (2024) · Expert Review of Neurotherapeutics
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 2
- Verified
Viloxazine Extended Release in Adults With Attention-Deficit/Hyperactivity Disorder and Depression and/or Anxiety Symptoms
Adler, L. A., Lieberman, V. R., Brijbasi, L., Mattingly, G. W., Yarullina, I., Li, Y., Earnest, J., & Rubin, J. (2026) · The Journal of Clinical Psychiatry
Attention Deficit Hyperactivity DisorderSchizophrenia research and treatment
Cited by 1
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free